These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36799682)

  • 1. Hepatitis C Among People Who Inject Drugs (PWID) in Latin America and the Caribbean: A Meta-Analysis of Prevalence Over Three Decades.
    Magri MC; Manchiero C; Dantas BP; da Silva Nunes AK; Vaz Gago Prata T; Domingos DEA; Dos Santos Nascimento G; Alvarez MSM; Bernardo WM; Tengan FM
    J Stud Alcohol Drugs; 2023 Jan; 84(1):118-127. PubMed ID: 36799682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.
    Tengan FM; Ibrahim KY; Dantas BP; Manchiero C; Magri MC; Bernardo WM
    BMC Infect Dis; 2016 Nov; 16(1):663. PubMed ID: 27829381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
    Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Stone J; Fraser H; Lim AG; Walker JG; Ward Z; MacGregor L; Trickey A; Abbott S; Strathdee SA; Abramovitz D; Maher L; Iversen J; Bruneau J; Zang G; Garfein RS; Yen YF; Azim T; Mehta SH; Milloy MJ; Hellard ME; Sacks-Davis R; Dietze PM; Aitken C; Aladashvili M; Tsertsvadze T; Mravčík V; Alary M; Roy E; Smyrnov P; Sazonova Y; Young AM; Havens JR; Hope VD; Desai M; Heinsbroek E; Hutchinson SJ; Palmateer NE; McAuley A; Platt L; Martin NK; Altice FL; Hickman M; Vickerman P
    Lancet Infect Dis; 2018 Dec; 18(12):1397-1409. PubMed ID: 30385157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis.
    Alonso M; Gutzman A; Mazin R; Pinzon CE; Reveiz L; Ghidinelli M
    Int J Public Health; 2015 Nov; 60(7):789-98. PubMed ID: 26298439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van Den Boom W; Walker JG; Ward Z; Stone J; Vickerman P;
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the number of people who inject drugs using repeated respondent-driven sampling (RDS) in a community-based program: implications for the burden of hepatitis C and HIV infections and harm reduction coverage.
    Roussos S; Paraskevis D; Malliori M; Hatzakis A; Sypsa V
    AIDS Behav; 2023 Feb; 27(2):424-430. PubMed ID: 35947234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
    Bruggmann P; Blach S; Deltenre P; Fehr J; Kouyos R; Lavanchy D; Müllhaupt B; Rauch A; Razavi H; Schmid P; Semela D; Stoeckle M; Negro F
    Swiss Med Wkly; 2017; 147():w14543. PubMed ID: 29120012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
    Rajabi A; Sharafi H; Alavian SM
    Harm Reduct J; 2021 Jan; 18(1):12. PubMed ID: 33482831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
    Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G
    Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis.
    Tengan FM; Abdala E; Nascimento M; Bernardo WM; Barone AA
    BMC Infect Dis; 2017 Aug; 17(1):587. PubMed ID: 28836955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal.
    Curado A; Nogueira PJ; Virgolino A; Santa Maria J; Mendão L; Furtado C; Antunes F
    Front Public Health; 2022; 10():952909. PubMed ID: 36081480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernández D
    Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.